Symposium and Biobran Trial Protocol Formulation

Major symposium was held on December 29 to 31 October 2009, which is located at Hotel Sanur Paradise Plaza, Bali. Attended by about 250 doctors from all over Indonesia, the symposium was able to invite many national and international pharmaceutical companies, among others, Kalbe, Sanofi Aventis, Astra Zeneca, Combiphar, Actavis, Soho, Novartis, Pfizer, Merck and PT Ferron PAR PharmaCeuticals Biobran product that presents itself , Docetere and Cytogem.

With the theme "KONKER PERABOI DAN TEMU RISET NASIONAL", this symposium lift the title "Immunomudulation and it's benefit for cancer patients focusing Biobran" by Dr. Achmad Dimyati Sp. B (K) Onk. as a speaker. Also present were dr. Eddy Herman Tanggo that discuss the topic "Overview Cancer Supporting Theraphy". For information, Biobran this symposium is one part of a symposium on "Symposia Cancer Supporting Theraphy" headed by Dr. INW Steven Christian, Sp. B (K) Onk.

Motivated by evidence Biobran effective in working with cancer patients, the purpose of the symposium is to increase sales Biobran Biobran trial protocol and begin to formulate education center Biobran by surgical oncology. Overall, the show lively and the participants were very enthusiastic in discussing the problem of supporting Therapy.


-Slamet Risdiyanto-
-Editor by P. Agus Setiawan-

Date Release: 
Thursday, October 29, 2009 - 06:00